Clinical Trials in Brazil

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Artificial intelligence in clinical trials in Brazil

Artificial intelligence in clinical trials in Brazil – Top CRO in Latin America

Artificial Intelligence (AI) has emerged as a powerful tool in healthcare, transforming various aspects of patient care and medical research. In Brazil, AI is revolutionizing the landscape of clinical trials, offering tremendous potential for improving efficiency, accuracy, and patient outcomes.

This blog explores how AI is reshaping clinical trials in Brazil, highlighting its impact on patient recruitment, trial design, data analysis, safety monitoring, and drug development.

Enhancing Patient Recruitment and Selection

Patient recruitment and selection are critical factors in the success of clinical trials. AI-powered algorithms and machine learning techniques are revolutionizing these processes in Brazil.

By analyzing vast amounts of patient data, electronic health records (EHRs), and genetic information, AI can identify eligible candidates more efficiently. This expedites the enrollment process, ensures diverse participant representation, and improves the generalizability of study results.

Optimizing Trial Design and Protocol

AI plays a pivotal role in optimizing trial design and protocol development in Brazil. By analyzing historical clinical trial data, AI algorithms can identify patterns and insights that aid researchers in refining study designs, selecting appropriate endpoints, and determining optimal sample sizes.

AI also enables adaptive trial designs, allowing real-time adjustments based on ongoing data analysis. This flexibility enhances trial efficiency and enables researchers to address unforeseen challenges effectively.

Improving Data Collection and Analysis

Accurate and comprehensive data collection and analysis are crucial in clinical trials. AI-powered technologies, such as natural language processing (NLP) and image recognition, streamline data extraction from various sources, including medical records, laboratory reports, and imaging scans.

This reduces manual data entry, minimizes errors, and enhances data accuracy. AI algorithms can rapidly analyze collected data, identifying trends, correlations, and adverse events that might otherwise be overlooked, thus improving the reliability of research outcomes.

Artificial intelligence in clinical trials in Brazil

Enhancing Safety Monitoring and Pharmacovigilance

Patient safety is of utmost importance in clinical trials, and AI significantly contributes to safety monitoring and pharmacovigilance in Brazil. AI algorithms continuously monitor patient data, detecting potential adverse events or safety concerns in real-time and alerting healthcare professionals for prompt intervention.

By analyzing diverse data sets, including vital signs, laboratory values, and patient-reported outcomes, AI algorithms can identify abnormal patterns or deviations, ensuring patient safety throughout the trial process.

Accelerating Drug Discovery and Development

AI has the potential to accelerate drug discovery and development in Brazil. AI-powered tools analyze vast repositories of scientific literature, clinical trial data, and molecular information to identify potential drug targets, predict drug efficacy, and optimize drug formulations.

Virtual screening methods driven by AI can rapidly screen and prioritize thousands of compounds, significantly reducing time and cost compared to traditional experimental methods. This acceleration of the drug development process holds promise for faster access to innovative treatments in Brazil.


Artificial Intelligence is transforming clinical trials in Brazil, revolutionizing patient recruitment, trial design, data analysis, safety monitoring, and drug development. By harnessing the power of AI, Brazil’s healthcare system can overcome challenges and improve patient outcomes.

Embracing AI-driven technologies enhances the efficiency and effectiveness of clinical trials, paving the way for personalized medicine and tailored treatment approaches. As AI continues to evolve, its integration into clinical trials in Brazil will drive innovation, leading to improved healthcare and better patient care.

Source: Duke Clinical Research Institute

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Clinical Trials in Brazil

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
Clinical Trials in Brazil

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Clinical Trials in Brazil

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Clinical Trials in Brazil

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

Clinical Trials in Brazil

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

Clinical Trials in Brazil

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
Clinical Trials in Brazil

The Cohortias Team

Clinical Trials in Brazil

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Clinical Trials in Brazil

Network & Partnerships